Products
DEPLETED URANIUM
- Department of Defense (DOD) Health Affairs (HA) Policy 03-012 —Policy for the Operation Iraqi Freedom Depleted Uranium (DU) Medical Management
- Urine Testing for Depleted Uranium —FAQs RE: depleted uranium
- Depleted Uranium for Service Members and their Families —from the Deployment Health and Family Readiness Library
- Depleted Uranium Information for Clinicians —from the Deployment Health Clinical Center
- US Army Public Health Command (USAPHC), Just the Facts—Depleted Uranium
- Department of the Army (DA) depleted uranium (DU) Policy Memo 11-047 —Medical management of Army personnel exposed to DU. More info: Deployment Health Clinical Center
- Supplemental Information and Clinical Guidance for DOD Depleted Uranium (DU) Medical Management Program
POTASSIUM IODIDE
- DOD Health Affairs (HA) Policy 04-012 —Policy regarding the use of potassium iodide (KI) for the protection of U.S. service personnel and family members
- Frequently Asked Questions on Potassium Iodide (KI) —Questions are answered by the FDA
PRUSSIAN BLUE THERAPY FOR RADIOCESIUM CONTAMINATION
- Q&A on Prussian blue —Questions are answered by the FDA
- AFRRI guidelines —Use of Prussian blue (Radiogardase™) for treatment of internal radiocesium contamination, supplements Food and Drug Administration (FDA) guidance
- AFRRI Prussian blue work sheet —Form describing the initial assessment and treatment of casualties from a radiation dispersal device (RDD) event that involves the dispersal of radioactive cesium or thallium
- DoD HA Policy 05-007 (download) —Procedures for using Prussian blue (ferric hexacyanoferrate or Radiogardase™), approved by the FDA for patients with known or suspected internal contamination with radioactive cesium and/or radioactive or nonradioactive thallium
- FDA label for Radiogardase™ —Manufacturer's product information for capsules containing Prussian blue insoluble powder